img

Ipilimumab Industry: Global Market Opportunities and Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 432 | Industry : Pharma & Healthcare

Publisher : MRG | Format : PDF

Ipilimumab Industry: Global Market Opportunities and Forecast 2024-2034

This report provides a comprehensive analysis of current global Ipilimumab market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Ipilimumab industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Ipilimumab market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Ipilimumab Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Ipilimumab market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Ipilimumab Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Ipilimumab industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions


Segmented by Type
PD - L1 Antagonists
CTLA4 Antagonists

Segmented by Application
Cancer
Melanoma

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Prestige BioPharma
Ono
Gilead
BMS
Baxter
Avacta


Table of Content

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Ipilimumab Market Status and Forecast (2016-2027)
1.3.2 Global Ipilimumab Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Ipilimumab Supply by Company
2.1 Global Ipilimumab Sales Volume by Company
2.2 Global Ipilimumab Sales Value by Company
2.3 Global Ipilimumab Price by Company
2.4 Ipilimumab Production Location and Sales Area of Main Manufacturers
2.5 Trend of Concentration Rate
3 Global and Regional Ipilimumab Market Status by Type
3.1 Ipilimumab Type Introduction
3.1.1 PD - L1 Antagonists
3.1.2 CTLA4 Antagonists
3.1.3 Immunocheckpoint Inhibitors
3.1.4 Other
3.2 Global Ipilimumab Market by Type
3.2.1 Global Ipilimumab Sales Volume by Type (2016-2021)
3.2.2 Global Ipilimumab Sales Value by Type (2016-2021)
3.2.3 Global Ipilimumab Price by Type (2016-2021)
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Ipilimumab Market Status by Application
4.1 Ipilimumab Segment by Application
4.1.1 Cancer
4.1.2 Melanoma
4.2 Global Ipilimumab Market by Application
4.2.1 Global Ipilimumab Sales Volume by Application (2016-2021)
4.2.2 Global Ipilimumab Sales Value by Application (2016-2021)
4.2.3 Global Ipilimumab Price by Application (2016-2021)
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Ipilimumab Market Status by Region
5.1 Global Ipilimumab Market by Region
5.1.1 Global Ipilimumab Sales Volume by Region
5.1.2 Global Ipilimumab Sales Value by Region
5.2 North America Ipilimumab Market Status
5.3 Europe Ipilimumab Market Status
5.4 Asia Pacific Ipilimumab Market Status
5.5 Central & South America Ipilimumab Market Status
5.6 Middle East & Africa Ipilimumab Market Status
6 North America Ipilimumab Market Status
6.1 North America Ipilimumab Market by Country
6.1.1 North America Ipilimumab Sales Volume by Country (2016-2021)
6.1.2 North America Ipilimumab Sales Value by Country (2016-2021)
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Ipilimumab Market Status
7.1 Europe Ipilimumab Market by Country
7.1.1 Europe Ipilimumab Sales Volume by Country (2016-2021)
7.1.2 Europe Ipilimumab Sales Value by Country (2016-2021)
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Ipilimumab Market Status
8.1 Asia Pacific Ipilimumab Market by Country
8.1.1 Asia Pacific Ipilimumab Sales Volume by Country (2016-2021)
8.1.2 Asia Pacific Ipilimumab Sales Value by Country (2016-2021)
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Ipilimumab Market Status
9.1 Central & South America Ipilimumab Market by Country
9.1.1 Central & South America Ipilimumab Sales Volume by Country (2016-2021)
9.1.2 Central & South America Ipilimumab Sales Value by Country (2016-2021)
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Ipilimumab Market Status
10.1 Middle East & Africa Ipilimumab Market by Country
10.1.1 Middle East & Africa Ipilimumab Sales Volume by Country (2016-2021)
10.1.2 Middle East & Africa Ipilimumab Sales Value by Country (2016-2021)
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
11.1 Supply Chain Analysis
11.2 Production Process Chart Analysis
11.3 Raw Materials and Key Suppliers Analysis
11.3.1 Raw Materials Introduction
11.3.2 Raw Materials Key Suppliers List
11.4 Ipilimumab Manufacturing Cost Analysis
11.5 Ipilimumab Sales Channel and Distributors Analysis
11.5.1 Ipilimumab Sales Channel
11.5.2 Ipilimumab Distributors
11.6 Ipilimumab Downstream Major Buyers
12 Global Ipilimumab Market Forecast by Type and by Application
12.1 Global Ipilimumab Sales Volume and Sales Value Forecast (2022-2027)
12.2 Global Ipilimumab Forecast by Type
12.2.1 Global Ipilimumab Sales Volume Forecast by Type
12.2.2 Global Ipilimumab Sales Value Forecast by Type
12.2.3 Global Ipilimumab Price Forecast by Type
12.3 Global Ipilimumab Forecast by Application
12.3.1 Global Ipilimumab Sales Volume Forecast by Application
12.3.2 Global Ipilimumab Sales Value Forecast by Application
12.3.3 Global Ipilimumab Price Forecast by Application
13 Global Ipilimumab Market Forecast by Region/Country
13.1 Global Ipilimumab Market Forecast by Region (2022-2027)
13.1.1 Global Ipilimumab Sales Volume Forecast by Region (2022-2027)
13.1.2 Global Ipilimumab Sales Value Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Shenyang Sansheng Pharmaceutical
14.1.1 Company Information
14.1.2 Ipilimumab Product Introduction
14.1.3 Shenyang Sansheng Pharmaceutical Ipilimumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.1.4 SWOT Analysis
14.2 Roche
14.2.1 Company Information
14.2.2 Ipilimumab Product Introduction
14.2.3 Roche Ipilimumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.2.4 SWOT Analysis
14.3 Prestige BioPharma
14.3.1 Company Information
14.3.2 Ipilimumab Product Introduction
14.3.3 Prestige BioPharma Ipilimumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.3.4 SWOT Analysis
14.4 Ono
14.4.1 Company Information
14.4.2 Ipilimumab Product Introduction
14.4.3 Ono Ipilimumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.4.4 SWOT Analysis
14.5 Gilead
14.5.1 Company Information
14.5.2 Ipilimumab Product Introduction
14.5.3 Gilead Ipilimumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.5.4 SWOT Analysis
14.6 BMS
14.6.1 Company Information
14.6.2 Ipilimumab Product Introduction
14.6.3 BMS Ipilimumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.6.4 SWOT Analysis
14.7 Baxter
14.7.1 Company Information
14.7.2 Ipilimumab Product Introduction
14.7.3 Baxter Ipilimumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.7.4 SWOT Analysis
14.8 Avacta
14.8.1 Company Information
14.8.2 Ipilimumab Product Introduction
14.8.3 Avacta Ipilimumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.8.4 SWOT Analysis
15 Conclusion
16 Methodology

List of Figure

List of Tables

Table Global Ipilimumab Sales Value and CAGR by Region (2016-2027)
Table Global Ipilimumab Sales Volume by Company (2019-2021)
Table Global Ipilimumab Sales Volume Market Share by Company (2019-2021)
Table Global Ipilimumab Sales Value by Company (2019-2021)
Table Global Ipilimumab Sales Value and CAGR by Region (2016-2027)
Table Global Ipilimumab Price by Company (2019-2021)
Table Main Manufacturers Ipilimumab Product Location and Sales Area
Table Global Ipilimumab Sales Value by Company (2019-2021)
Table Global Ipilimumab Sales Volume by Type (2016-2021)
Table Global Ipilimumab Sales Volume Market Share by Type (2016-2021)
Table Global Ipilimumab Sales Value by Type (2016-2021)
Table Global Ipilimumab Sals Value Market Share by Type (2016-2021)
Table Global Ipilimumab Price by Type (2016-2021)
Table North America Ipilimumab Sales Volume by Type (2016-2021)
Table Global Ipilimumab Sales Value by Type (2016-2021)
Table Europe Ipilimumab Sales Volume by Type (2016-2021)
Table Europe Ipilimumab Sales Volume Market Share by Type (2016-2021)
Table Asia Pacific Ipilimumab Sales Volume by Type (2016-2021)
Table Asia Pacific Ipilimumab Sales Volume Market Share by Type (2016-2021)
Table Central & South America Ipilimumab Sales Volume by Type (2016-2021)
Table Central & South America Pacific Ipilimumab Sales Volume Market Share by Type (2016-2021)
Table Middle East & Africa Ipilimumab Sales Volume by Type (2016-2021)
Table Middle East & Africa Ipilimumab Sales Volume Market Share by Type (2016-2021)
Table Global Ipilimumab Sales Volume by Application (2016-2021)
Table Global Ipilimumab Sales Volume Market Share by Application (2016-2021)
Table Global Ipilimumab Sales Value by Application (2016-2021)
Table Global Ipilimumab Value Market Share by Application (2016-2021)
Table Global Ipilimumab Price by Application (2016-2021)
Table North America Ipilimumab Sales Volume by Application (2016-2021)
Table Global Ipilimumab Sales Value by Application (2016-2021)
Table Europe Ipilimumab Sales Volume by Application (2016-2021)
Table Europe Ipilimumab Sales Volume Market Share by Application (2016-2021)
Table Asia Pacific Ipilimumab Sales Volume by Application (2016-2021)
Table Asia Pacific Ipilimumab Sales Volume Market Share by Application (2016-2021)
Table Central & South America Ipilimumab Sales Volume by Application (2016-2021)
Table Central & South America Pacific Ipilimumab Sales Volume Market Share by Application (2016-2021)
Table Middle East & Africa Ipilimumab Sales Volume by Application (2016-2021)
Table Middle East & Africa Ipilimumab Sales Volume Market Share by Application (2016-2021)
Table Global Ipilimumab Sales Volume by Region (2016-2021)
Table Global Ipilimumab Sales Volume Market Share by Region (2016-2021)
Table Global Ipilimumab Sales Value by Region (2016-2021)
Table Global Ipilimumab Value Market Share by Region (2016-2021)
Table North America Ipilimumab Sales Volume by Country (2016-2021)
Table North America Ipilimumab Sales Volume Market Share by Country (2016-2021)
Table Global Ipilimumab Sales Value by Region/Country (2016-2021)
Table North America Ipilimumab Value Market Share by Country (2016-2021)
Table Europe Ipilimumab Sales Volume by Country (2016-2021)
Table Europe Ipilimumab Sales Volume Market Share by Country (2016-2021)
Table Europe Ipilimumab Sales Value by Country (2016-2021)
Table Europe Ipilimumab Value Market Share by Country (2016-2021)
Table Asia Pacific Ipilimumab Sales Volume by Country (2016-2021)
Table Asia Pacific Ipilimumab Sales Volume Market Share by Country (2016-2021)
Table Asia Pacific Ipilimumab Sales Value by Country (2016-2021)
Table Asia Pacific Ipilimumab Value Market Share by Country (2016-2021)
Table Central & South America Ipilimumab Sales Volume by Country (2016-2021)
Table Central & South America Ipilimumab Sales Volume Market Share by Country (2016-2021)
Table Central & South America Ipilimumab Sales Value by Country (2016-2021)
Table Central & South America Ipilimumab Value Market Share by Country (2016-2021)
Table Middle East & Africa Ipilimumab Sales Volume by Country (2016-2021)
Table Middle East & Africa Ipilimumab Sales Volume Market Share by Country (2016-2021)
Table Middle East & Africa Ipilimumab Sales Value by Country (2016-2021)
Table Middle East & Africa Ipilimumab Value Market Share by Country (2016-2021)
Table Ipilimumab Raw Materials Key Suppliers List
Table Ipilimumab Distributors List
Table Ipilimumab Buyers List
Table Global Ipilimumab Sales Volume Forecast by Type (2022-2027)
Table Global Ipilimumab Sales Volume Market Share Forecast by Type (2022-2027)
Table Global Ipilimumab Value Forecast by Type (2022-2027)
Table Global Ipilimumab Value Market Share Forecast by Type (2022-2027)
Table Global Ipilimumab Price Forecast by Type (2022-2027)
Table Global Ipilimumab Sales Volume Forecast by Application (2022-2027)
Table Global Ipilimumab Value Forecast by Type (2022-2027)
Table Global Ipilimumab Value Forecast by Application (2022-2027)
Table Global Ipilimumab Value Market Share Forecast by Application (2022-2027)
Table Global Ipilimumab Price Forecast by Application (2022-2027)
Table Global Ipilimumab Sales Volume Forecast by Region (2022-2027)
Table Global Ipilimumab Value Forecast by Application (2022-2027)
Table Global Ipilimumab Value Forecast by Region (2022-2027)
Table Global Ipilimumab Value Market Share Forecast by Region (2022-2027)
Table Shenyang Sansheng Pharmaceutical Company Information
Table Shenyang Sansheng Pharmaceutical Product Introduction
Table Global Ipilimumab Value Forecast by Region (2022-2027)
Table Roche Company Information
Table Roche Product Introduction
Table Roche Ipilimumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Prestige BioPharma Company Information
Table Prestige BioPharma Product Introduction
Table Prestige BioPharma Ipilimumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Ono Company Information
Table Ono Product Introduction
Table Ono Ipilimumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Gilead Company Information
Table Gilead Product Introduction
Table Gilead Ipilimumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table BMS Company Information
Table BMS Product Introduction
Table BMS Ipilimumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Baxter Company Information
Table Baxter Product Introduction
Table Baxter Ipilimumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
Table Avacta Company Information
Table Avacta Product Introduction
Table Avacta Ipilimumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021)